Interestingly, NAFLD was also associated with higher 1-year rehospitalization rates after excluding either those with serum GGT levels >60 U/L and ALT >30 U/L (HR 2.66, 95% CI 1.1–6.9, P = 0.02) or those with rehospitalization in the early postdischarge period, that is, rehospitalizations at 1 month (HR 3.64, 95% CI 1.6–8.1, P = 0.001). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.